Effects of host modulation by nonsteroidal anti-inflammatory drugs on periodontal disease: a systematic review and meta-analysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Nonsteroidal anti-inflammatory drugs that prohibit biosynthesis of arachidonic acid metabolites have been considered potent host modulation agents. The aim of this review was to determine the effect of nonsteroidal anti-inflammatory drugs adjunctive with nonsurgical periodontal treatment in patients with periodontal disease. Materials and Methods: Three electronic databases were searched to identify relevant studies. The methodological quality and mean differences of the change in clinical attachment level and probing depth were analyzed according to Cochrane review methods. Results: Twelve studies were included in the methodological assessment and nine studies were suitable for inclusion in the meta-analysis. The mean difference in the clinical attachment level gain did not differ significantly between the nonsteroidal anti-inflammatory drugs and control groups at any observation time. The highest mean difference in clinical attachment level gain was 0.30 mm at 4 weeks (95% confidence interval = -0.37 to 0.97). There was a significant mean difference in the probing depth reduction, of 0.34 mm (95% confidence interval =0.29 to 0.40) at 6 weeks. Conclusion: Therefore, nonsteroidal anti-inflammatory drugs have additional therapeutic effect when administrated with nonsurgical periodontal treatment.
Abstract
Purpose: Nonsteroidal anti-inflammatory drugs that prohibit biosynthesis of arachidonic acid metabolites have been considered potent host modulation agents. The aim of this review was to determine the effect of nonsteroidal anti-inflammatory drugs adjunctive with nonsurgical periodontal treatment in patients with periodontal disease. Materials and Methods: Three electronic databases were searched to identify relevant studies. The methodological quality and mean differences of the change in clinical attachment level and probing depth were analyzed according to Cochrane review methods. Results: Twelve studies were included in the methodological assessment and nine studies were suitable for inclusion in the meta-analysis. The mean difference in the clinical attachment level gain did not differ significantly between the nonsteroidal anti-inflammatory drugs and control groups at any observation time. The highest mean difference in clinical attachment level gain was 0.30 mm at 4 weeks (95% confidence interval = -0.37 to 0.97). There was a significant mean difference in the probing depth reduction, of 0.34 mm (95% confidence interval =0.29 to 0.40) at 6 weeks. Conclusion: Therefore, nonsteroidal anti-inflammatory drugs have additional therapeutic effect when administrated with nonsurgical periodontal treatment.
참고문헌 (40)
- Consensus, "Periodontal diseases: pathogenesis and microbial factors", Ann Periodontol, 1, pp.926~932 (1996)
- Havemose-Poulsen A, "Polymorphisms within the IL-1 gene cluster: effects on cytokine profiles in peripheral blood and whole blood cell cultures of patients with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis", J Periodontol, 78, pp.475~492 (2007)
- Löe H, "Periodontal disease. The sixth complication of diabetes mellitus", Diabetes Care, 16, pp.329~334 (1993)
- Tomar SL, "Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey", J Periodontol, 71, pp.743~751 (2000)
- Cobb CM, "Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing", J Clin Periodontol, 29(Suppl 2), pp.6~16 (2002)
- Haffajee AD, "Survival analysis of periodontal sites before and after periodontal therapy", J Clin Periodontol, 12, pp.553~567 (1985)
- Giannobile WV, "Patient stratification for preventive care in dentistry", J Dent Res, 92, pp.694~701 (2013)
- Kornman KS, "The host response to the microbial challenge in periodontitis:assembling the players", Periodontol 2000, 14, pp.33~53 (1997)
- Page RC, "The role of inflammatory mediators in the pathogenesis of periodontal disease", J Periodontal Res, 26(3 Pt 2), pp.230~242 (1991)
- Lane N, "Bisphosphonate therapy improves the outcome of conventional periodontal treatment: results of a 12-month, randomized, placebo-controlled study", J Periodontol, 76, pp.1113~1122 (2005)
- Leitão RF, "Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats", J Periodontol, 76, pp.956~963 (2005)
- Gisele Lago Martinez, "Serum level changes of long chain-polyunsaturated fatty acids in patients undergoing periodontal therapy combined with one year of omega-3 supplementation: a pilot randomized clinical trial", Journal of Periodontal & Implant Science, 44(4), pp.169~177 (2014), 대한치주과학회
- Martuscelli G, "The effect of interleukin-11 on the progression of ligature-induced periodontal disease in the beagle dog", J Periodontol, 71, pp.573~578 (2000)
- Offenbacher S, "The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss", J Periodontal Res, 21, pp.101~112 (1986)
- Caton JG, "Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis", J Periodontol, 71, pp.521~532 (2000)
- Preshaw PM, "Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial", J Periodontol, 75, pp.1068~1076 (2004)
- Reddy MS, "Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review", Ann Periodontol, 8, pp.12~37 (2003)
- Higgins JP, "Cochrane handbook for systematic reviews of interventions, vol. 5" (2008), Wiley Online Library
- "System for information on grey literature in Europe"[URL]
- Armitage GC, "Development of a classification system for periodontal diseases and conditions", Ann Periodontol, 4, pp.1~6 (1999)
- Cohen J, "Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit", Psychol Bull, 70, pp.213~220 (1968)
- Higgins JP, "The Cochrane Collaboration's tool for assessing risk of bias in randomised trials", BMJ, 343, pp.d5928~ (2011)
- "A service of the U.S. National Institutes of Health" (2000)[URL]
- Higgins JP, "Measuring inconsistency in meta-analyses", BMJ, 327, pp.557~560 (2003)
- Aras H, "Effect of systemically administered naproxen sodium on clinical parameters and myeloperoxidase and elastase-like activity levels in gingival crevicular fluid", J Periodontol, 78, pp.868~873 (2007)
- Azoubel MC, "Adjunctive benefits of systemic etoricoxib in non-surgical treatment of aggressive periodontitis:short-term evaluation", J Periodontol, 79, pp.1719~1725 (2008)
- Buduneli N, "Clinical findings and gingival crevicular fluid prostaglandin E2 and interleukin-1-beta levels following initial periodontal treatment and short-term meloxicam administration", Expert Opin Pharmacother, 11, pp.1805~1812 (2010)
- Jeffcoat MK, "Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis", J Periodontal Res, 26, pp.415~421 (1991)
- Ng VW, "Clinical evaluation of systemic doxycycline and ibuprofen administration as an adjunctive treatment for adult periodontitis", J Periodontol, 69, pp.772~776 (1998)
- Ozgören O, "The adjunctive effect of tenoxicam during non-surgical periodontal treatment on clinical parameters and gingival crevicular fluid levels of MMP-8 and TNF-alpha in patients with chronic periodontitis - randomized, double-blind clinical trial", Adv Clin Exp Med, 23, pp.559~565 (2014)
- Reddy MS, "Efficacy of meclofenamate sodium (Meclomen) in the treatment of rapidly progressive periodontitis", J Clin Periodontol, 20, pp.635~640 (1993)
- Taiyeb Ali TB, "The effect of systemic ibuprofen on gingival inflammation in humans", J Clin Periodontol, 20, pp.723~728 (1993)
- Vardar S, "Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis", J Periodontol, 74, pp.57~63 (2003)
- Knowles JW, "Results of periodontal treatment related to pocket depth and attachment level. Eight years", J Periodontol, 50, pp.225~233 (1979)
- Rostom A, "Prevention of NSAIDinduced gastroduodenal ulcers", Cochrane Database Syst Rev, 4, pp.CD002296~ (2002)
- Slomiany BL, "Nonsteroidal antiinflammatory drugs impair oral mucosal repair by eliciting disturbances in endothelin-converting enzyme-1 and constitutive nitric oxide synthase", J Physiol Pharmacol, 52, pp.81~92 (2001)
- Kotsakis GA, "Association between low-dose aspirin and periodontal disease: results from the continuous national health and nutrition examination survey (NHANES) 2011-2012", J Clin Periodontol, 42, pp.333~341 (2015)
- Salvi GE, "Host response modulation in the management of periodontal diseases", J Clin Periodontol, 32(Suppl 6), pp.108~129 (2005)
- Salvi GE, "The effects of non-steroidal anti-inflammatory drugs (selective and non-selective)on the treatment of periodontal diseases", Curr Pharm Des, 11, pp.1757~1769 (2005)
- Thomson WM, "Partial- or full-mouth approaches to assessing the prevalence of and risk factors for periodontal disease in young adults", J Periodontol, 73, pp.1010~1014 (2002)
